By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported 10 percent first-quarter revenue growth led by its SAFC business. On an organic basis, its revenues were up around 4 percent year over year.

The St. Louis-based chemicals and research tools firm brought in total revenues of $572 million for the three-month period ended March 31 compared to $519 million for the first quarter of 2009. The firm beat analysts' consensus estimate of $570.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.